Top 26 Prexton Therapeutics investors
The most complete profiles first. Showing 26 of 26.
Antoine BoulangerVerified
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Cristina GarmendiaVerified
Venture Capital · Spain
SeedPre-SeedHealth CareWomen FoundedLife ScienceManufacturingPortfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more
Verified email available
Noga YerushalmiVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Israel
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
Owen LozmanVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Netherlands
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
Anastasia KarpovaVerified
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Javier RodriguezVerified
Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany
Health CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Verified email available
John MontanaVerified
Venture Capital, Private Equity Firm, Investment Partner · United Kingdom
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Verified email available
Cheryl Zimberlin
Venture Capital, Corporate Venture Capital, Investor · Netherlands
SeedHealth CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Christian Patze
Venture Capital, Corporate Venture Capital, Private Equity Firm · Germany
SeedHealth CareDeepTechConsumer GoodsInfrastructurePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Geert
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Holger Reithinger
Venture Capital, Investor · Germany
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Juliette Audet
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Martien van Osch
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 64 more
Contact details available
Rogier Rooswinkel
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wouter Joustra
Venture Capital, Investor · Netherlands
SeedHealth CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Asiya Giniatullina
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Bonnie van Wilgenburg
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Carlo Incerti
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Guillem Laporta, CFA
Venture Capital, Private Equity Firm · Spain
Health CareWomen FoundedLife ScienceManufacturingPortfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more
Contact details available
Iñigo López
Venture Capital, Private Equity Firm · Spain
Health CareWomen FoundedLife ScienceManufacturingPortfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more
Contact details available
Jessica Vitos
Venture Capital · Spain
Health CareWomen FoundedLife ScienceManufacturingPortfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more
Contact details available
Jordi Xiol
Venture Capital, Private Equity Firm · Spain
Health CareWomen FoundedLife ScienceManufacturingPortfolio: TiGenix, AM Pharma, Ona Therapeutics, STAT-Dx and 27 more
Contact details available
Julian Schubert
Venture Capital, Corporate Venture Capital · Germany
Health CareConsumer GoodsInfrastructureChemicalPortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
Sander van Deventer
Venture Capital · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Vincent van Houten
Venture Capital, Private Equity Firm, Investment Partner · Netherlands
Health CareGeneticsWellnessLife SciencePortfolio: Santaris Pharma, AM Pharma, Pathway Medical Technologies, Impella Cardiosystems and 63 more
Contact details available
Wallace Wallace
Venture Capital, Corporate Venture Capital · Netherlands
Health CareConsumer GoodsInfrastructureLife SciencePortfolio: FoRx Therapeutics, Micropsi Industries, Indi Molecular, Biolinq and 48 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Prexton Therapeutics investors are on Angel Roster?
Angel Roster lists 26 Prexton Therapeutics investors. 7 of them (27%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (26), Private Equity Firms (13) and Corporate Venture Capital Firms (7). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Prexton Therapeutics investors invest in?
Among those that list a stage, the most common are Seed (12) and Pre-Seed (1).
Where are Prexton Therapeutics investors based?
Most are based in the Netherlands (15), Spain (5) and Germany (4).
Which companies have Prexton Therapeutics investors backed?
The most-backed portfolio companies among them are SANIFIT (19), AM Pharma (19), BioVex (19), Cardoz (19) and Pathway Medical Technologies (14).
How do I contact Prexton Therapeutics investors?
Create a free Angel Roster account to search and filter all 26, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.